Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation
Seeking Alpha
Friday, April 5, 2013 - 10:23am
tags:
Pfizer, JNJ, GSK, Abbott Laboratories, Merck, Novartis
AstraZeneca, Rigel arthritis pill disappoints again
Reuters
Friday, April 5, 2013 - 10:22am
tags:
Rigel, AstraZeneca, fostamatinib, rheumatoid arthritis
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Friday, April 5, 2013 - 10:21am
tags:
Merck, Endocyte, Eli Lilly, Pfizer, Repligen, AbbVie, Protalix BioTherapeutics
GlaxoSmithKline Launches Phase 3 Trial for Benlysta
Motley Fool
Friday, April 5, 2013 - 10:19am
tags:
GSK, Benlysta, ANCA-positive vasculitis
Yervoy-Zelboraf combo trial stopped on toxicity worries
Fierce Pharma
Thursday, April 4, 2013 - 2:05pm
tags:
Zelboraf, Yervoy, Bristol-Myers Squibb, melanoma, Roche
3 Biopharmas With Significant Potential
Seeking Alpha
Thursday, April 4, 2013 - 2:02pm
tags:
Inovio, MannKind, Titan Pharmaceuticals
Biogen Idec up after positive MS drug study
Marketwatch
Thursday, April 4, 2013 - 1:54pm
tags:
Biogen Idec, MS, multiple sclerosis, AbbVie, daclizumab
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thursday, April 4, 2013 - 1:52pm
tags:
investors, psoriasis, Amgen, Eli Lilly, Pfizer, Novartis, Celgene, Humira, AbbVie, Stelara, Remicade, Enbrel, apremilast, brodalumab, Xeljanz
Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs
Yahoo/AP
Thursday, April 4, 2013 - 1:49pm
tags:
Amylin, Bristol-Myers Squibb, layoffs
Why Zohydro May Or May Not Be Approved
Seeking Alpha
Thursday, April 4, 2013 - 1:49pm
tags:
Zohydro ER, Zogenix, migraines
J&J Wins Reversal of $482 Million Patent Verdict Over Stents
Bloomberg
Thursday, April 4, 2013 - 1:47pm
tags:
JNJ, stents, patents, Cordis, Cypher
Ariad CEO Strikes Back, Insists Leukemia Drug Is Fine
TheStreet.com
Thursday, April 4, 2013 - 1:44pm
tags:
CML, Ariad Pharmaceuticals, Iclusig
NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
Yahoo
Thursday, April 4, 2013 - 9:35am
tags:
NewLink Genetics, NLG919, IDO pathway inhibitors, cancer
Cyclacel says Celgene will buy 4 patents related to Istodax for $5.5M, resolving lawsuits
Yahoo/AP
Thursday, April 4, 2013 - 9:25am
tags:
Istodax, Cyclacel, Celgene, patents
Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
Seeking Alpha
Thursday, April 4, 2013 - 9:24am
tags:
Amgen, Amarantus BioSciences, Novartis, Gilead, biotech, Roche, Teva
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thursday, April 4, 2013 - 9:22am
tags:
lung cancer, Merrimack Pharmaceuticals, MM-121, non-small cell lung cancer
Illumina Launches TruSight™ Tumor Content Set
Yahoo
Thursday, April 4, 2013 - 9:21am
tags:
Illumina, devices, TruSight, solid tumors
Pfizer’s Read Finds Reason to Keep Consumer Health Unit
Bloomberg
Thursday, April 4, 2013 - 9:19am
tags:
Ian Read, Pfizer, OTC
Pfizer Recalls Thyroid-Disorder Drug Over Odor Problem
FOX Business
Thursday, April 4, 2013 - 9:18am
tags:
recalls, Pfizer, Levoxyl, thyroid
Experimental sleep drug may cause fewer side effects -Merck study
Reuters
Thursday, April 4, 2013 - 9:16am
tags:
Merck, suvorexant, insomnia, Lunesta, Ambien

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.